DelveInsight’s “Complex Regional Pain Syndrome (CRPS) Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Complex Regional Pain Syndrome market size, share, and trends in the seven major market (7MM) (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).
The Complex Regional Pain Syndrome market report covers emerging drugs, current treatment practices, market share of individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, key drivers & barriers impacting the market growth, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
Complex Regional Pain Syndrome: An Overview
Complex regional pain syndrome (CRPS) is a broad term describing excess and prolonged pain and inflammation that follows an injury to an arm or leg or any part of the body. CRPS is clinically characterized by sensory, autonomic, and motor disturbances; it can affect any body part but occurs most often in the extremities. Complex regional pain syndrome can develop after different types of injuries, such as sprains and strains, surgeries, fractures, contusions, nerve lesions, stroke, etc.
There are no objective diagnostic tests for CRPS. Since the pathophysiologic basis of CRPS is not fully understood, mechanism-based diagnosis is not yet feasible. Therefore, CRPS diagnoses are based solely on clinical signs and symptoms. The actual diagnosis of CRPS is made solely based on history and physical examination to determine whether a patient meets CRPS diagnostic criteria (often called the Budapest criteria).
Complex Regional Pain Syndrome (CRPS) Market Key Facts
-
According to DelveInsight’s analysis, in the year 2017, the total prevalent case of Complex Regional Pain Syndrome (CRPS) was 310,400+ in the 7MM.
-
In EU-5 countries, the highest number of diagnosed cases of CRPS was in Germany, followed by France, the United Kingdom, Italy, and Spain.
-
The United States, in 2017, accounted for 219,300+ Complex Regional Pain Syndrome (CRPS) prevalent cases (the highest number among 7MM).
-
There is currently no cure or medication that has been approved for CRPS specifically. The goal of currently available treatment is to manage the pain and to increase the mobility of the affected limbs.
Complex Regional Pain Syndrome (CRPS) Market
As per Delveinsight, in 2017, the Complex Regional Pain Syndrome (CRPS) Market size was USD 65 million in the 7MM, which is expected to grow by 2032.
The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Complex Regional Pain Syndrome market size by analyzing the impact of current and emerging pipeline therapies. It also provides a thorough assessment of the market drivers & barriers, unmet needs, and emerging technologies set to impact the market dynamics.
The report gives complete detail of the Complex Regional Pain Syndrome market trend for each marketed drug and mid & late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, their Mechanism of Action (MoA), Route of Administration (RoA), molecule types, competition with other therapies, brand value, and their impact on the market.
Complex Regional Pain Syndrome (CRPS) Epidemiology Assessment
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted epidemiology trends by exploring numerous studies and research. The epidemiology section also provides a detailed analysis of diagnosed and prevalent patient pool, future trends, and and views of key opinion leaders.
The Report Provides Complex Regional Pain Syndrome (CRPS) Epidemiology Segmentation Based on –
-
Total Prevalent Cases of CRPS
-
Total Diagnosed Prevalent cases of CRPS
-
Treated cases of CRPS
-
Gender-specific Diagnosed Prevalent Cases of CRPS
-
Age-specific Diagnosed Prevalent Cases of CRPS
-
Type-specific Diagnosed Prevalent Cases of CRPS
-
Severity-Specific Diagnosed Prevalent Cases of CRPS
Complex Regional Pain Syndrome (CRPS) Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Complex Regional Pain Syndrome market or expected to get launched during the study period. The analysis covers the Complex Regional Pain Syndrome market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Complex Regional Pain Syndrome Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Learn How Complex Regional Pain Syndrome Market Will Evolve by 2032 @
https://www.delveinsight.com/sample-request/complex-regional-pain-syndrome-market
Complex Regional Pain Syndrome (CRPS) Therapeutics Analysis
The pipeline developmental activity around Complex Regional Pain Syndrome is pretty scarce because it is poorly defined, resulting in underdiagnosed and fewer treatment options; it is anticipated that with a better understanding of the condition, there is going to be an upsurge in this particular segment in the coming years.
Some of the key companies in the Complex Regional Pain Syndrome (CRPS) Market include:
-
Ovid Therapeutics
-
Takeda
-
AstraZeneca
-
Biohaven Pharmaceutical
-
Grunenthal/Medifron
And many others.
Complex Regional Pain Syndrome (CRPS) Therapies Covered in the Report Include
-
Soticlestat (TAK-935/OV935)
-
BHV-5000
-
Non-narcotic Strong Analgesic (TRPV1 Antagonist)
And others.
Further Emerging Drugs & Key Companies are Covered in the Report. Download the Sample PDF to Learn More @
https://www.delveinsight.com/sample-request/complex-regional-pain-syndrome-market
Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Complex Regional Pain Syndrome Competitive Intelligence Analysis
4. Complex Regional Pain Syndrome Market Overview at a Glance
5. Complex Regional Pain Syndrome Disease Background and Overview
6. Complex Regional Pain Syndrome Patient Journey
7. Complex Regional Pain Syndrome Epidemiology and Patient Population (In the US, EU5, and Japan)
8. Complex Regional Pain Syndrome Treatment Algorithm, Current Treatment, and Medical Practices
9. Complex Regional Pain Syndrome Unmet Needs
10. Key Endpoints of Complex Regional Pain Syndrome Treatment
11. Complex Regional Pain Syndrome Marketed Products
12. Complex Regional Pain Syndrome Emerging Drugs and Latest Therapeutic Advances
13. Complex Regional Pain Syndrome Seven Major Market Analysis
14. Attribute Analysis
15. Complex Regional Pain Syndrome Market Outlook (In US, EU5, and Japan)
16. Complex Regional Pain Syndrome Access and Reimbursement Overview
17. KOL Views on the Complex Regional Pain Syndrome Market
18. Complex Regional Pain Syndrome Market Drivers
19. Complex Regional Pain Syndrome Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.
Download Sample PDF to Explore the Key Offerings of the Report @
https://www.delveinsight.com/sample-request/complex-regional-pain-syndrome-market
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Interested in learning about the latest clinical and commercial developments in the medical devices market? Visit for more detailed information: MedTech Market Outlook
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/